104 related articles for article (PubMed ID: 7248159)
1. Value of serum calcitonin estimation in clinical oncology.
Mulder H; Hackeng WH; Silberbusch J; den Ottolander GJ; van der Meer C
Br J Cancer; 1981 Jun; 43(6):786-92. PubMed ID: 7248159
[TBL] [Abstract][Full Text] [Related]
2. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin concentrations in lung cancer and non-malignant pulmonary diseases.
Yiakoumakis E; Proukakis C; Raptis K; Korres A; Dondas N; Samaras V
Oncology; 1987; 44(3):145-9. PubMed ID: 3601315
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoreactive calcitonin concentrations in hepatocellular carcinoma.
Dugard J; Kew MC; da Fonseca M; Levin J
S Afr Med J; 1982 Aug; 62(9):271-3. PubMed ID: 6287652
[TBL] [Abstract][Full Text] [Related]
5. Plasma calcitonin and tumors.
Tabolli S; Valtorta C; Scarda A; D'Erasmo E; Minisola S; Antonelli R; Medori C; Mazzuoli G
Tumori; 1983 Jun; 69(3):227-30. PubMed ID: 6868140
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin in hepatoma and cirrhosis.
Conte N; Cecchettin M; Manente P; Valmachino G; Roiter I; Pavan P
Acta Endocrinol (Copenh); 1984 May; 106(1):109-11. PubMed ID: 6328818
[TBL] [Abstract][Full Text] [Related]
7. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
Body JJ; Dumon JC; Sculier JP; Dabouis G; Lacroix H; Libert P; Richez M; Bureau G; Mommen P; Raymakers N
Henry Ford Hosp Med J; 1989; 37(3-4):190-3. PubMed ID: 2639133
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen (CEA) in patients with malignant and non-malignant diseases.
Alsabti EA; Kamel A
Neoplasma; 1979; 26(5):603-9. PubMed ID: 230422
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin as a marker for bronchogenic cancer: a prospective study.
Silva OL; Broder LE; Doppman JL; Snider RH; Moore CF; Cohen MH; Becker KL
Cancer; 1979 Aug; 44(2):680-4. PubMed ID: 476577
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
Becker KL; Snider RH; Silva OL; Moore CF
Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
[TBL] [Abstract][Full Text] [Related]
12. Serum immunoreactive calcitonin in lung cancer.
Conte N; Cecchettin M; Manente P; Monco MA; Salandin F; Volpato E; Roiter I; Carniato A
Tumori; 1984 Apr; 70(2):137-40. PubMed ID: 6328714
[TBL] [Abstract][Full Text] [Related]
13. A study of immunoreactive calcitonin (CT), adrenocorticotropic hormone (ACTH) and carcinoembryonic antigen (CEA) in lung cancer and other malignancies.
Krauss S; Macy S; Ichiki AT
Cancer; 1981 May; 47(10):2485-92. PubMed ID: 6268270
[TBL] [Abstract][Full Text] [Related]
14. Increased serum calcitonin levels in bronchogenic cancer.
Silva OL; Becker KL; Primack A; Doppman JL; Snider RH
Chest; 1976 Apr; 69(4):495-9. PubMed ID: 177250
[TBL] [Abstract][Full Text] [Related]
15. [Serum beta 2-microglobulin and carcinoembryonic antigen in patients with bronchogenic carcinoma].
Cha RJ; Chen SJ; Xiao CZ; Liang XL; Zhou NK
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):342-4. PubMed ID: 3552534
[TBL] [Abstract][Full Text] [Related]
16. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
17. Urine calcitonin levels in patients with bronchogenic carcinoma.
Becker KL; Nash DR; Silva OL; Snider RH; Moore CF
JAMA; 1980 Feb; 243(7):670-2. PubMed ID: 6243372
[TBL] [Abstract][Full Text] [Related]
18. Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma.
Dent PB; McCulloch PB; Wesley-James O; MacLaren R; Muirhead W; Dunnett CW
Cancer; 1978 Sep; 42(3 Suppl):1484-91. PubMed ID: 709519
[TBL] [Abstract][Full Text] [Related]
19. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
20. Editorials: elevated plasma calcitonin as a marker for bronchogenic carcinoma.
Williams GA
Chest; 1976 Apr; 69(4):451. PubMed ID: 1261308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
